Xiangmin Cui

Insider Reports History

Entity
Individual
Location
No. 14 East Hushan Road, Tai'an City, Shandong, China
Signature
/s/ Xiangmin Cui
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Xiangmin Cui:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. Director Class A Common Stock 17.1M $50.7M $2.97 Sep 4, 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Class A Common Stock 7.61M $22.6M $2.97 Sep 4, 2024 By Decheng Capital Global Healthcare Fund (Master), LP
Nuvation Bio Inc. Director Class A Common Stock 1.28M $3.81M $2.97 Sep 4, 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
Cue Health Inc. Director Common Stock 788K $237K $0.30 Sep 28, 2021 Indirect
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 0 $0 $6.33 May 18, 2024 Indirect
Nuvation Bio Inc. Director Warrants (Right to Buy) 438K Sep 3, 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Warrants (Right to Buy) 175K Sep 3, 2024 By Decheng Capital Global Healthcare Fund (Master), LP
Nuvation Bio Inc. Director Warrants (Right to Buy) 32.9K Sep 3, 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Stock Option (Right to buy) 0 May 20, 2024 Direct
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Warrant (right to buy) 0 Jan 18, 2024 Indirect
Cue Health Inc. Director Series C-1 Preferred Stock 0 Sep 28, 2021 Indirect
Nuvation Bio Inc. Director Series A Preferred Stock 0 Sep 4, 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Series A Preferred Stock 0 Sep 4, 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
Nuvation Bio Inc. Director Series A Preferred Stock 0 Sep 4, 2024 By Decheng Capital Global Healthcare Fund (Master), LP

Insider Reports Filed by Xiangmin Cui

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVB Nuvation Bio Inc. Sep 3, 2024 12 $0 4 Sep 5, 2024 Director
NUVB Nuvation Bio Inc. Jun 25, 2024 1 $825K 4 Jun 26, 2024 Director
NUVB Nuvation Bio Inc. Jun 20, 2024 3 $1.49M 4 Jun 25, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. May 18, 2024 8 $0 4 May 20, 2024 Director, 10%+ Owner
NUVB Nuvation Bio Inc. Apr 9, 2024 3 $0 4 Apr 11, 2024 Director
NUVB Nuvation Bio Inc. Apr 9, 2024 0 $0 3 Apr 11, 2024 Director
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 18, 2024 2 $15.7M 4 Jan 22, 2024 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Nov 9, 2023 1 $4.69M 4 Nov 14, 2023 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 23, 2022 2 $14.7M 4 Sep 27, 2022 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Jan 3, 2022 1 $0 4 Jan 4, 2022 Director, 10%+ Owner
HLTH Cue Health Inc. Sep 28, 2021 3 $10.1M 4 Sep 30, 2021 Director
HLTH Cue Health Inc. Sep 23, 2021 0 $0 3 Sep 23, 2021 Director, 10%+ Owner
ALPN ALPINE IMMUNE SCIENCES, INC. Sep 17, 2021 1 $14.5M 4 Sep 21, 2021 Director, 10%+ Owner